Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | 191,000 | 274,000 | -19,000 | 257,000 | 242,000 |
| Other Working Capital | -618,000 | -311,000 | 2,305,000 | 164,000 | -1,993,000 |
| Other Operating Activity | 1,540,000 | 995,000 | 910,000 | 1,791,000 | 3,058,000 |
| Operating Cash Flow | $1,113,000 | $958,000 | $3,196,000 | $2,212,000 | $1,307,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -300,000 | -247,000 | -479,000 | -288,000 | -293,000 |
| Net Acquisitions | 1,169,000 | 312,000 | 958,000 | -73,000 | -542,000 |
| Purchase Sale Intangibles | -139,000 | -288,000 | -297,000 | -198,000 | -231,000 |
| Other Investing Activity | 41,000 | 101,000 | 86,000 | 68,000 | 110,000 |
| Investing Cash Flow | $770,000 | $-149,000 | $268,000 | $-491,000 | $-964,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -539,000 | -323,000 | -2,755,000 | -1,288,000 | 1,042,000 |
| Debt Issued | N/A | N/A | -15,000 | N/A | N/A |
| Debt Repayment | 0 | 0 | 0 | 6,000 | -6,000 |
| Common Stock Issued | 1,000 | 18,000 | 1,000 | 0 | 3,000 |
| Dividend Paid | -652,000 | -568,000 | -568,000 | -567,000 | -557,000 |
| Other Financing Activity | -394,000 | -187,000 | -255,000 | 87,000 | -451,000 |
| Financing Cash Flow | $-1,584,000 | $-1,060,000 | $-3,592,000 | $-1,762,000 | $31,000 |
| Exchange Rate Effect | -8,000 | -19,000 | -34,000 | 23,000 | -57,000 |
| Beginning Cash Position | 2,588,000 | 2,858,000 | 3,020,000 | 3,038,000 | 2,721,000 |
| End Cash Position | 2,879,000 | 2,588,000 | 2,858,000 | 3,020,000 | 3,038,000 |
| Net Cash Flow | $299,000 | $-251,000 | $-128,000 | $-41,000 | $374,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,113,000 | 958,000 | 3,196,000 | 2,212,000 | 1,307,000 |
| Capital Expenditure | -442,000 | -563,000 | -783,000 | -497,000 | -535,000 |
| Free Cash Flow | 671,000 | 395,000 | 2,413,000 | 1,715,000 | 772,000 |